METHODS: Thirty consecutive patients with renal tumor and IVC thrombus were treated between July 2011 and October 2018. Baseline, perioperative and follow-up data were collected into a prospectively maintained IRB approved databases. Surgical technique has been previously described. We report perioperative and oncologic outcomes of 30 consecutive patients treated in a tertiary referral center.
INTRODUCTION AND OBJECTIVES: Partial Nephrectomy (PN) is the standard treatment of renal tumor under 4 cm. Ablative therapy (AT) has emerged as alternative to surgery.
The aim was to compare oncologic and perioperative outcomes of PN and AT in small renal masses, by using a Trifecta score (minimal renal function decrease, absence of complication and failure-free survival (FFS)).
METHODS: A single-center, retrospective study was conducted, including all consecutive patients treated for cT1a renal tumor from 2010 to 2014.
Main endpoints collected were their complexity (RENAL score), perioperative data (lenght of hospital stay, complications (ClavienDindo), glomerular filtration rate (GFR)) and oncological outcomes.
Trifecta was achieved when renal function had less than a 20 % variation, a complication Clavien 3, and no recurrence (FFS).
Chi2 test was used to compare the qualitative variables, t-test (Student) for the quantitative variables.
Overall and failure-free survival were analyzed according to Kaplan-Meier and compared by log-rank test.
RESULTS: From 2010 to 2014, 248 patients were included (131 AT and 117 PN). Median follow-up was 64 months in both groups.
Patients treated by AT were significantly older (70 vs 61 y, p<0.0001), with higher ASA score (2.34 vs 2, p<0.0001), smaller but not more complex tumors (63 % of RENAL score 6 in AT group vs 62 % in PN group, p[0.64). Renal function was better in PN group.
Trifecta was analyzable in 97% of patients. It was achieved in 70,7% of patients treated by PN (n[82) vs 70, 9% (n[90) in the AT group (p[0.97).
Overall survival was significantly better in the PN group (89,7% vs AT 75,6%, p[0.0064).
Failure-free survival was comparable in both groups (91,5% in PN group vs 87% in AT group, p[0.21).
Variation of glomerular filtration rate (CKD-EPI) was comparable in both groups (-3,8% vs -4,3% in AT and PN, ns).
There was no difference in terms of complications according to Clavien, 4,6% vs 6,8% of Clavien 3-5 for AT vs PN.
CONCLUSIONS: Partial Nephrectomy and ablatives techniques offer good results with long term follow-up (five years); percutaneous ablation should be discussed in fragile patients. The Trifecta score appears as a useful model in comparing the management of small renal tumors.
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INTRODUCTION AND OBJECTIVES:
To compare the oncologic outcomes of patients who underwent Open partial nephrectomy (OPN), Laparoscopic partial nephrectomy (LPN) and Robotic partial nephrectomy (RPN) at mid-long term follow upMETHODS: Patients were stratified according to the surgical technique: OPN vs LPN vs RPN. Differences in categorical and continuous variables were analyzed using the chi-squared test and the Mann-Whitney U-test, respectively. Outcomes of interest: disease free survival (DFS) and cancer-specific survival (CSS) were plotted using Kaplan-Meier survival curves. The association between oncologic outcomes and clinicopathological features and techniques were assessed using a univariable and multivariable Cox proportional hazard model. RESULTS: Of 547 patients, 293 (54%), 153 (28%) and 101 (19%) underwent OPN, LPN and RPN, respectively. RPN was associated with high PADUA risk compared to OPN and LPN (19% vs 12% vs 10%; p[0.03) (Table 1b) .
